Searle & Co’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
5,600
+100
+2% +$18.4K 0.24% 84
2026
Q1
$1.04M Hold
5,500
0.26% 81
2025
Q4
$1.09M Hold
5,500
0.28% 71
2025
Q3
$1.12M Hold
5,500
0.3% 75
2025
Q2
$968K Hold
5,500
0.27% 80
2025
Q1
$740K Hold
5,500
0.21% 88
2024
Q4
$694K Hold
5,500
0.2% 92
2024
Q3
$914K Hold
5,500
0.23% 79
2024
Q2
$732K Sell
5,500
-100
-2% -$12K 0.17% 94
2024
Q1
$589K Hold
5,600
0.15% 98
2023
Q4
$423K Hold
5,600
0.12% 110
2023
Q3
$369K Hold
5,600
0.13% 108
2023
Q2
$418K Hold
5,600
0.13% 106
2023
Q1
$411K Buy
+5,600
New +$311K 0.13% 107

Other funds holding THC

Searle & Co's THC Position: Q2 2026 in Review

Searle & Co increased its Tenet Healthcare (THC) stake by 1.8% in Q2 2026, buying an estimated $18.4K and bringing the position to 5,600 shares worth $1.05M. The position accounts for 0.24% of the portfolio, ranked #84.

Searle & Co first reported a position in THC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.12M in Q3 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Searle & Co held 5,600 shares of Tenet Healthcare worth $1.05M as of Q2 2026.
  • Searle & Co bought 100 Tenet Healthcare shares in Q2 2026, an estimated $18.4K.
  • Tenet Healthcare made up 0.24% of Searle & Co's portfolio in Q2 2026, its #84 holding.
  • Searle & Co first reported a position in Tenet Healthcare in Q1 2023 and has held it in 14 quarters since.
  • Searle & Co's Tenet Healthcare position peaked at $1.12M in Q3 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Searle & Co's 13F filing for Q2 2026, filed 27 Jul 2026.